510(k) Report

510(k) · Cleared

Cleared

On Call Sure Blood Glucose Monitoring System, On Call Sure Sync Blood Glucose Monitoring System

K181527510(k) TraditionalCleared Oct 3, 2018114-day reviewClass II21 CFR 862.1345

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

ACON Laboratories, Inc. · NBW System, Test, Blood Glucose, Over The Counter

Cleared on Oct 3, 2018 as substantially equivalent to K130284 (ACON Laboratories, Inc., 2013) after a 114-day review. Its family tree reaches back 3 generations to 2000. 1 later device descends from it.

Decided
Oct 3, 2018
Review
114 days
Class
Class II
Product code
NBW
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K002134 (2000). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2020: 1 descendant clearedReference device: K913806 · Ysi Model 2300 Stat Plus · Ysis, Inc. · 1991K002134 · One Touch Ultra Blood Glucose Monitoring System · Selfcare, Inc. · 2000K112653 · ON Call Vivid Blood Glucose Monitoring Systems · ACON Laboratories, Inc. · 2012K130284 · ON Call Sharp Blood Glucose Monitoring System · ACON Laboratories, Inc. · 2013200020052010201520202025
Descendants, by generation 1 generation forward: 1 descendant K130284 · ON Call Sharp Blood Glucose Monitoring System · ACON Laboratories, Inc. · 2013K112653 · ON Call Vivid Blood Glucose Monitoring Systems · ACON Laboratories, Inc. · 2012K002134 · One Touch Ultra Blood Glucose Monitoring System · Selfcare, Inc. · 20000
  1. Root · 3 generations backK002134 One Touch Ultra Blood Glucose Monitoring SystemSelfcare, Inc. · 2000
  2. 2 generations backK112653 ON Call Vivid Blood Glucose Monitoring SystemsACON Laboratories, Inc. · 2012
  3. 1 generation backK130284 ON Call Sharp Blood Glucose Monitoring SystemACON Laboratories, Inc. · 2013
  4. This deviceK181527 On Call Sure Blood Glucose Monitoring System, On Call Sure Sync…ACON Laboratories, Inc. · 2018
  5. Descendant · cites it directly · 0 of its ownK200277 Livongo Blood Glucose Monitoring System (BG1000)Livongo Health, Inc. · 2020

Most influential descendants

Showing 1 of 1 · See all
  • K200277Livongo Blood Glucose Monitoring System (BG1000)Livongo Health, Inc. · 2020 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K002134One Touch Ultra Blood Glucose Monitoring SystemSelfcare, Inc.2000—
−2K112653ON Call Vivid Blood Glucose Monitoring SystemsACON Laboratories, Inc.2012—
−1K130284ON Call Sharp Blood Glucose Monitoring SystemACON Laboratories, Inc.2013—
0 (this device)K181527On Call Sure Blood Glucose Monitoring System, On Call Sure Sync Blood Glucose…ACON Laboratories, Inc.2018—
+1K200277Livongo Blood Glucose Monitoring System (BG1000)Livongo Health, Inc.2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202010
FIG. 1 — Lineage of K181527, 2000–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NBW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBW device

  1. #1 K260545 CONTOUR® PLUS BLUE Blood Glucose Monitoring…score 14.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K130284ON Call Sharp Blood Glucose Monitoring System
Summary page 5
…System Predicate Device: On Call Sharp Blood Glucose Monitoring System ACON Laboratories, Inc. 10125 Mesa Rim Rd, San Diego, CA 92121 510(k) Number: K130284 Device Name: On Call Sure Blood Glucose Monitoring System On Call Sure Sync Blood Glucose Monitoring System…
ACON Laboratories, Inc.2013—
†K913806Ysi Model 2300 Stat PlusYsis, Inc.1991—

Also cleared against K130284: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K200277Livongo Blood Glucose Monitoring System (BG1000)Livongo Health, Inc.20200

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 2 companies; a new generation was cleared every 4.8 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K200277 (Livongo Health, Inc., 2020) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K130284.

How does its category compare?

All NBW devices

NBW System, Test, Blood Glucose, Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · NBW

2in 2025

2007: 292008: 372009: 382010: 312011: 302012: 302013: 472014: 242015: 322016: 202017: 252018: 192019: 102020: 72021: 72022: 122023: 52024: 72025: 22026 (partial year): 5
2007high 47 (2013) · low 2 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBW

243in 2024

2007: 85 days median2008: 128 days median2009: 140 days median2010: 132 days median2011: 328 days median2012: 230 days median2013: 167 days median2014: 202 days median2015: 237 days median2016: 233 days median2017: 244 days median2018: 168 days median2019: 127 days median2020: 121 days median2021: 465 days median2022: 410 days median2023: 193 days median2024: 243 days median2026 (partial year): 190 days median
2007high 465 (2021) · low 85 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBW

1in 2025

2007: 92008: 22009: 52010: 112011: 12012: 12013: 5, 2 Class I2014: 12016: 12019: 142025: 1
2007high 14 (2019) · low 0 (2015)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · NBW

4,745in 2025

2007: 7,9912008: 7,7042009: 10,9632010: 11,6312011: 22,9092012: 23,4492013: 35,4082014: 38,5242015: 62,1112016: 76,6212017: 37,5382018: 16,9112019: 14,4722020: 10,7032021: 9,1982022: 8,1032023: 7,2562024: 6,2202025: 4,745
2007high 76,621 (2016) · low 4,745 (2025)2025

MAUDE reports naming product code NBW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007298597,991
20083712827,704
200938140510,963
2010311321111,631
201130328122,909
201230230123,449
2013471675 (2)35,408
201424202138,524
201532237062,111
201620233176,621
201725244037,538
201819168016,911
2019101271414,472
20207121010,703
2021746509,198
20221241008,103
2023519307,256
2024724306,220
20252—14,745
202651900—

What is it indicated for?

The On Call Sure Blood Glucose Monitoring System is comprised of the On Call Sure Blood Glucose Meter and On Call Sure Blood Glucose Test Strips. The On Call Sure Blood Glucose Monitoring System is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood from the fingertips, forearm and palm. The On Call Sure Blood Glucose Monitoring System is intended for self-testing by people with diabetes at home as an aid to…

Read the full statement (323 words)

The On Call Sure Blood Glucose Monitoring System is comprised of the On Call Sure Blood Glucose Meter and On Call Sure Blood Glucose Test Strips. The On Call Sure Blood Glucose Monitoring System is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood from the fingertips, forearm and palm. The On Call Sure Blood Glucose Monitoring System is intended for self-testing by people with diabetes at home as an aid to monitoring the effectiveness of diabetes control programs. The On Call Sure Blood Glucose Monitoring System is intended for single-patient use and should not be shared.

The On Call Sure Blood Glucose Monitoring System is for in vitro diagnostic use. The On Call Sure Blood Glucose Monitoring System is not intended for the diagnosis of or screening for diabetes, nor intended for use on neonates. Alternative site testing should be done only during steady-state times (when glucose is not changing rapidly).

The On Call Sure Sync Blood Glucose Monitoring System is comprised of the On Call Sure Sync Blood Glucose Meter and On Call Sure Blood Glucose Test Strips. The On Call Sure Sync Blood Glucose Monitoring System is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood from the fingertips, forearm and palm. The On Call Sure Sync Blood Glucose Monitoring System is intended for self-testing by people with diabetes at home as an aid to monitoring the effectiveness of diabetes control programs. The On Call Sure Sync Blood Glucose Monitoring System is intended for single-patient use and should not be shared.

The On Call Sure Sync Blood Glucose Monitoring System is for in vitro diagnostic use. The On Call Sure Sync Blood Glucose Monitoring System is not intended for the diagnosis of or screening for diabetes, nor intended for use on neonates. Alternative site testing should be done only during steady-state times (when glucose is not changing rapidly).

Indications for use as stated in the FDA summary.

Also cleared against K130284

1 other device cites the same predicate.

  • K193340GoChek Blood Glucose Monitoring System, GoChek Connect Blood Glucose Monitoring SystemMicrotech Medical, Inc. · 2020

More from ACON Laboratories, Inc.

86 FDA decisions under this applicant name. See the company

  • K261212Flowflex Plus RSV + Flu A/B + COVID Rapid TestACON Laboratories, Inc. · 2026
  • K251697Flowflex® Plus Strep A Rapid Test Cassette; Flowflex® Plus Strep A Rapid Test StripACON Laboratories, Inc. · 2025
  • K251749Flowflex Plus RSV + Flu A/B + COVID Home TestACON Laboratories, Inc. · 2025
  • K250085On Call® Sure GK Blood Glucose & Ketone Monitoring System; On Call® Sure Sync GK Blood Glucose & Ketone…ACON Laboratories, Inc. · 2025
  • K250377Flowflex Plus COVID-19 + Flu A/B Home TestACON Laboratories, Inc. · 2025

Recent decisions in NBW

The NBW category page

  • K261293EASYMAX Voice Blood Glucose Monitoring SystemEPS Bio Technology Corp. · 2026
  • K260687VivaChek Blood Glucose and ß-Ketone Dual BLE Monitoring System;VivaChek Blood Glucose and ß-Ketone Dual…Vivachek Biotech (Hangzhou) Co., Ltd. · 2026
  • K260689CVS Advanced PLUS Blood Glucose Monitoring SystemI-Sens, Inc. · 2026
  • K260545CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring System…Ascensia Diabetes Care · 2026
  • K262116TRUE METRIX Self Monitoring Blood Glucose SystemTrividia Health, Inc. · 2026

https://510kreport.com/device/K181527 · printed Nov 6, 2026

Cite this page

510(k) Report. “K181527: On Call Sure Blood Glucose Monitoring System, On Call Sure Sync Blood Glucose Monitoring System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K181527

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026